0.0280
-0.0010
(-3.45%)
At close: 3:10:55 PM GMT+13
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NZD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Paul Naske | Chief Executive Officer | 232.69k | -- | -- |
Mr. Panapa Ehau | Co-Founder & Executive Director | 45k | -- | -- |
Mr. Liam Walker | Virtual Chief Financial Officer | -- | -- | -- |
Tony Robinson | Compliance & Business Development Manager | -- | -- | -- |
Paul Woroniecki | Head of Quality | -- | -- | -- |
Mr. Len Walker | Head of Cultivation at Mangaoporo | -- | -- | -- |
Mr. John Sanders | Chief of Sales & Marketing of Australia | -- | -- | -- |
Rua Bioscience Limited
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. The company offers cannabinoid derived medicines. It is also involved in seed production and genetic discovery related activities. In addition, the company engages in plant breeding business, as well as involved in plant research activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founded in 2016 and is based in Gisborne, New Zealand.
Corporate Governance
Rua Bioscience Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 25, 2025 at 10:59 AM UTC - March 3, 2025 at 12:00 PM UTC
Rua Bioscience Limited Earnings Date
Recent Events
Recent Events Information Not Available